Screening New Drugs for Immunotoxic Potential: II. Assessment of the Effects of Selective and Nonselective COX-2 Inhibitors on Complement Activation, Superoxide Anion Production and Leukocyte Chemotaxis and Migration Through Endothelial Cells

REFERENCES

• Aronoff D. M., Bloch K. C. Assessing the relationship between the use of nonsteroidal anti-inflammatory drugs and necrotizing fasciitis caused by group A streptococcus. Medicine 2003; 82: 225–235, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Auteri A., Saletti M., Blardi P., DiPerri T. Action of a new non-steroidal anti-inflammatory drug, nimesulide, on activation of the complement system: An in vitro study. Int. J. Tissue React. 1988; 4: 217–221
   Google Scholar
• Bjorquist P., Palmer M., Bengt E. K. Measurement of superoxide anion production using maximal rate of cytochrome (III) C reduction in phorbol ester stimulated neutrophils, immobilized to microtiter plates. Biochem. Pharmacol. 1994; 48: 1967–1972, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Browne B. A., Holder E. P., Rupnick L. A. Nonsteroidal anti-inflammatory drugs and necrotizing faciitis. Am. J. Health-Syst. Pharm. 1996; 53: 265–269, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M., Strober W. Preparation and functional analysis of human nonlymphoid cells. Current Protocols in Immunology, J. E. Coligan, B. E. Bierer, D. H. Margulies, E. M. Shevach, W. Strober. John Wiley & Sons, New York 1993; 7.23.1–7.23.16
   Google Scholar
• Colville-Nash P. R., Gilroy D. W. Potential adverse effects of cyclooxygenase-2 inhibition: Evidence from animal models of inflammation. BioDrugs 2001; 15: 1–9, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Demeure C. E., Yang L. P., Desjardins C., Raynauld P., Delespesses G. Prostaglandin E primes naïve T-cells for the production of anti-inflammatory cytokines. Eur. J. Immunol. 1997; 27: 3526–3532, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Furst S. M., Khan K. N., Komocsar W. J., White K. L., Peachee V. L., Mennear J. H. Screening new drugs for immunotoxic potential: I. Assessment of the effects of conventional and selective COX-2-inhibiting NSAIDs on in vitro and in vivo phagocytic activity. J. Immunotoxicol. 2004; 1: 149–158, [CROSSREF]
   Google Scholar
• Himmelfarb J., Hakim R. M., Holbrook D. G., Leeber D. A., Ault K. A. Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry 1992; 13: 83–89, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hofbauer R., Speiser W., Kapiotis S. Ibuprofen inhibits leukocyte migration through endothelial cell monolayers. Life Sci. 1998; 62: 1775–1781, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kalinski P., Hilkens C. M., Snijders A., Snijdewint F. G., Kapsenberg M. L. IL-12-deficient dendritic cells, generated the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naïve T helper cells. J. Immunol. 1997; 159: 28–35, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Khan K. N., Stanfield K. M., Trajkovic D. T., Harris R. K. Cyclooxygenase-2 expression in inflammatory lung lesions of nonhuman primates. Vet. Pathol. 2000; 37: 512–516, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Korchak H. M., Vienne K., Rutherford L. E., Wilkenfeld C., Finkelstein M. C., Weissmann G. Stimulus-response coupling in the human neutrophil, II. Temporal analysis of changes in cytosolic calcium and calcium efflux. J. Biol. Chem. 1984; 259: 4076–4082, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Maloney C. G., Thompson S. D., Hill H. R., Bohnsack J. F., McIntyre J. F., Zimmerman G. A. Induction of cyclooxygenase-2 by human monocytes exposed to group B streptococci. J. Leukocyte Biol. 2000; 67: 615–621, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Maziasz T., Khan K. N., Talley J., Gierse J., Seibert K. The development of drugs that target cyclooxygenase-2. COX-2 Blockade in Cancer Prevention and Therapy. Humana Press Inc., Totowa, NJ 2003
   Google Scholar
• Miller C. W., Prescott J. F., Mathews K. A., Betschel S. D., Yager J. A., Guru V., DeWinter L., Low D. E. Streptococcal toxic shock syndrome in dogs. JAVMA 1996; 209: 1421–1426, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Minta J. O., Urowitz M. B., Smythe H. A., Isenman D. E. Effect on the human complement system of the major nonsteroidal anti-inflammatory drugs: Aspirin, indomethacin, phenylbutazone, oxyphenbutazone and sulindac. Clin. Exp. Immunol. 1983; 53: 555–561, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Newberry R. D., Stenson W. F., Lorenz R. G. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen. Nat. Med. 1999; 5: 900–906, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Segal A. W., Abo A. The biochemical basis of the NAPH oxidase of phagocytes. Trends Biochem. Sci. 1993; 18: 43–47, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stevens D. L. Could nonsteroidal anti-inflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?. Clin. Infect. Dis. 1995; 21: 977–980, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Sugawara T., Miyamoto M., Takayama S., Kato M. Separation of neutrophils from blood in human and laboratory animals and comparison of the chemotaxis. J. Pharm. Tox Meth. 1995; 33: 91–100, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tan A. S., Ahmed N., Berridge M. V. Acute regulation of glucose transport after activation of human peripheral blood neutrophils by phorbol myristate acetate, fMLP, and granulocyte-macrophage colony-stimulating factor. Blood 1998; 91: 549–655, [CSA]
   PubMed Web of Science ®Google Scholar
• Tanaka K., Tanaka H., Kanemoto Y., Tsuboi I. The effects of non-steroidal anti-inflammatory drugs on immune functions of human peripheral blood mononuclear cells. Immunopharmacology 1998; 40: 209–217, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Van d er, Pouw Kraan T. C., Boeije L. C., Smeenk R. J., Wijdenes J., Aarden L. A. Prostaglandin E2 is a potent inhibitor of human interleukin-12 production. J. Exp. Med. 1995; 181: 775–779, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Verfaillie G., Knape S., Corne L. A case of fatal necrotizing fasciitis after intramuscular administration of diclofenac. Eur. J. Emerg. Med. 2002; 9: 270–273, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMedGoogle Scholar
• Wu C. Y., Wang K., McDyer J. F., Seder R. A. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness. J. Immunol. 1998; 161: 2723–2730, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar